Table 5.
Comparison of clinical features in JAS and AAS patients with HLA-B∗2704 and B∗2705.
| HLA-B∗2704 | HLA-B∗2705 | ||||||
|---|---|---|---|---|---|---|---|
| JAS | AAS | P1 | JAS | AAS | P2 | ||
| Gender (male) | 112/120 (93.33%) | 237/275 (86.18%) | 0.042 | 10/11 (90.91%) |
33/38 (86.84%) |
0.720 | |
| Peripheral arthritis | 73/120 (60.83%) | 65/238 (27.31%) | <0.001 | 6/11 (54.54%) |
14/37 (37.84%) |
0.329 | |
| Enthesitis | 82/120 (68.33%) | 114/238 (47.90%) | <0.001 | 6/11 (54.54%) |
24/37 (64.86%) |
0.539 | |
| Hip arthritis | 49/120 (40.83%) | 48/241 (19.92%) | <0.001 | 4/11 (36.36%) |
5/32 (15.62%) |
0.303 | |
| Family histories | 34/120 (28.33%) | 54/238 (22.69%) | 0.207 | 3/11 (27.27%) |
7/37 (18.92%) |
0.553 | |
| Waxy digitus | 1/118 (0.85%) | 7/177 (3.95%) | 0.161 | 1/11 (9.09%) |
0/27 | 0.117 | |
| Iridocyclitis | 6/120 (0.05%) | 21/238 (8.82%) | 0.385 | 2/11 (18.18%) |
3/37 (8.11%) |
0.342 | |